CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Large Growth in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 190,400 shares, an increase of 2,438.7% from the October 31st total of 7,500 shares. Based on an average trading volume of 241,500 shares, the short-interest ratio is currently 0.8 days.

CNBX Pharmaceuticals Price Performance

CNBX opened at $0.01 on Thursday. CNBX Pharmaceuticals has a 1 year low of $0.01 and a 1 year high of $0.02. The company’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.